Finoriq research workspace
JOHNSON & JOHNSON (JNJ) Institutional Holdings & 13F Ownership
Johnson & Johnson engages in the research and development, manufacture, and sale of a range of. Review JNJ institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
- Company
- JOHNSON & JOHNSON (JNJ)
- Ticker
- JNJ
- Market Cap
- $600.2B
- Latest Price
- $249.32
- Industry
- Biotech & Pharma
JOHNSON & JOHNSON (JNJ) Top Institutional Holders
Top current 13F holders indexed for JOHNSON & JOHNSON (JNJ). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Ken FisherCIK 0000850529 | $2.3B | 0.77% | Filing2026-05-05 |
| 2 | Yacktman Asset ManagementCIK 0000905567 | $305.4M | 4.1% | Filing2026-05-01 |
| 3 | Ray DalioCIK 0001350694 | $170.3M | 0.76% | Filing2026-05-15 |
| 4 | Thomas GaynerCIK 0001096343 | $149.3M | 1.3% | Filing2026-05-01 |
| 5 | Mairs & Power FundsCIK 0001070134 | $141.2M | 1.4% | Filing2026-05-14 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.